Genfit reported first-half 2025 results and a strategic refocus in liver disease. The company ended June with €107.5 million...

Benitec Biopharma reported full-year 2025 results and advanced its lead program, announcing an independent data safety monitoring board recommendation...

Semnur Pharmaceuticals has closed its business combination with Denali Capital Acquisition Corp, creating a publicly traded entity that will...

Applied Pharmaceutical Innovation has launched the Life Sciences Placement Program in partnership with Mitacs, aiming to place 1,000 paid...

Angelini Pharma has secured an exclusive global option to develop and commercialize SVG105, a preclinical antisense oligonucleotide targeting the...

Achieve Life Sciences reported new peer-reviewed data showing its investigational agent, cytisinicline, significantly improved continuous abstinence rates versus placebo...

Cosmos Health has launched its U.S. operations with the debut of Sky Premium Life Noor Collagen, a marine collagen...

Immutep has initiated an investigator-initiated Phase II trial of eftilagimod alfa (efti) as a neoadjuvant therapy in early-stage HR+/HER2-negative...

Intellia Therapeutics will present longer-term data from its ongoing Phase 1 trial of Nexiguran ziclumeran (Nex-Z), an investigational in...

Starpharma has signed a collaboration and license agreement with Genentech to apply its DEP dendrimer drug-delivery platform to Genentech...